General Information of Drug Off-Target (DOT) (ID: OTE91EWT)

DOT Name Gremlin-2 (GREM2)
Synonyms Cysteine knot superfamily 1, BMP antagonist 2; DAN domain family member 3; Protein related to DAN and cerberus
Gene Name GREM2
Related Disease
Alzheimer disease ( )
Atrial fibrillation ( )
Diabetic kidney disease ( )
Myocardial infarction ( )
Osteoporosis ( )
Tooth agenesis ( )
Polycystic ovarian syndrome ( )
Neoplasm ( )
Gastric cancer ( )
Stomach cancer ( )
UniProt ID
GREM2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF03045
Sequence
MFWKLSLSLFLVAVLVKVAEARKNRPAGAIPSPYKDGSSNNSERWQHQIKEVLASSQEAL
VVTERKYLKSDWCKTQPLRQTVSEEGCRSRTILNRFCYGQCNSFYIPRHVKKEEESFQSC
AFCKPQRVTSVLVELECPGLDPPFRLKKIQKVKQCRCMSVNLSDSDKQ
Function
Cytokine that inhibits the activity of BMP2 and BMP4 in a dose-dependent manner, and thereby modulates signaling by BMP family members. Contributes to the regulation of embryonic morphogenesis via BMP family members. Antagonizes BMP4-induced suppression of progesterone production in granulosa cells.
KEGG Pathway
TGF-beta sig.ling pathway (hsa04350 )
Reactome Pathway
Signaling by BMP (R-HSA-201451 )

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Alzheimer disease DISF8S70 Strong Genetic Variation [1]
Atrial fibrillation DIS15W6U Strong Biomarker [2]
Diabetic kidney disease DISJMWEY Strong Biomarker [3]
Myocardial infarction DIS655KI Strong Biomarker [4]
Osteoporosis DISF2JE0 Strong Biomarker [5]
Tooth agenesis DIS1PWC7 Strong Genetic Variation [6]
Polycystic ovarian syndrome DISZ2BNG moderate Altered Expression [7]
Neoplasm DISZKGEW Disputed Genetic Variation [8]
Gastric cancer DISXGOUK Limited Altered Expression [9]
Stomach cancer DISKIJSX Limited Altered Expression [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Gremlin-2 (GREM2). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Gremlin-2 (GREM2). [20]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Gremlin-2 (GREM2). [21]
------------------------------------------------------------------------------------
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Gremlin-2 (GREM2). [11]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Gremlin-2 (GREM2). [12]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Gremlin-2 (GREM2). [13]
Vorinostat DMWMPD4 Approved Vorinostat decreases the expression of Gremlin-2 (GREM2). [14]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Gremlin-2 (GREM2). [15]
Dexamethasone DMMWZET Approved Dexamethasone decreases the expression of Gremlin-2 (GREM2). [16]
Niclosamide DMJAGXQ Approved Niclosamide decreases the expression of Gremlin-2 (GREM2). [17]
Dasatinib DMJV2EK Approved Dasatinib increases the expression of Gremlin-2 (GREM2). [18]
Permethrin DMZ0Q1G Approved Permethrin decreases the expression of Gremlin-2 (GREM2). [19]
SNDX-275 DMH7W9X Phase 3 SNDX-275 decreases the expression of Gremlin-2 (GREM2). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)

References

1 Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's disease.Mol Psychiatry. 2013 May;18(5):568-75. doi: 10.1038/mp.2012.81. Epub 2012 Jun 19.
2 Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm.Dis Model Mech. 2013 Mar;6(2):332-41. doi: 10.1242/dmm.010488. Epub 2012 Dec 7.
3 Grem2 mediates podocyte apoptosis in high glucose milieu.Biochimie. 2019 May;160:113-121. doi: 10.1016/j.biochi.2019.02.015. Epub 2019 Mar 1.
4 Gremlin2 Regulates the Differentiation and Function of Cardiac Progenitor Cells via the Notch Signaling Pathway.Cell Physiol Biochem. 2018;47(2):579-589. doi: 10.1159/000490012. Epub 2018 May 22.
5 Genetic variants in GREM2 are associated with bone mineral density in a southern Chinese population.J Clin Endocrinol Metab. 2013 Sep;98(9):E1557-61. doi: 10.1210/jc.2013-1983. Epub 2013 Jul 31.
6 GREM2 nucleotide variants and the risk of tooth agenesis.Oral Dis. 2018 May;24(4):591-599. doi: 10.1111/odi.12793. Epub 2017 Nov 3.
7 Gremlin-1 and gremlin-2 levels in polycystic ovary syndrome and their clinical correlations.Gynecol Endocrinol. 2019 Jul;35(7):604-607. doi: 10.1080/09513590.2019.1566452. Epub 2019 Feb 4.
8 Target genes of the WNT/beta-catenin pathway in Wilms tumors.Genes Chromosomes Cancer. 2006 Jun;45(6):565-74. doi: 10.1002/gcc.20319.
9 GREM2 maintains stem cell-like phenotypes in gastric cancer cells by regulating the JNK signaling pathway.Cell Cycle. 2019 Oct;18(19):2414-2431. doi: 10.1080/15384101.2019.1646561. Epub 2019 Aug 25.
10 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
11 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
12 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
13 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
14 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
15 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
16 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
17 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
18 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
19 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
20 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
21 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.